Medicare's AI Prior Authorization Test Cuts Medical Services Sharply
Medicare piloted AI-driven prior authorizations to curb wasteful spending, resulting in an immediate and significant decline in approved medical services.
Medicare has begun testing artificial intelligence to handle prior authorization decisions, a move designed to reduce unnecessary medical spending — but the experiment quickly produced a notable drop in the volume of medical services approved for patients, according to a MarketWatch report.
Prior authorization is the process by which insurers and government health programs require providers to obtain approval before delivering certain treatments, procedures, or medications. By automating that gatekeeping function with AI, Medicare aims to streamline reviews and flag potentially wasteful care before it occurs.
Read more Late-Forming Super PACs Pump $637M Into 2026 Midterm Races →
The immediate consequence of the AI-driven system, however, was a sharp reduction in medical services — raising questions among patient advocates and healthcare providers about whether the technology is denying necessary care alongside genuinely unnecessary procedures. Critics of automated prior authorization systems have long warned that algorithmic decision-making can lack the clinical nuance required to evaluate individual patient circumstances.
The pilot reflects a broader push within federal health programs to harness machine learning to control costs, which have grown steadily as the Medicare population expands. Supporters argue that AI can process authorization requests faster and more consistently than human reviewers, potentially reducing administrative burdens on providers and speeding up care decisions when approvals are granted.
The outcome of the Medicare trial is expected to inform policy decisions about how widely AI-assisted prior authorization could be deployed across the program. Continue reading at MarketWatch.com
